Avantor, Inc. (AVTR) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 26. On ...

Avantor, Inc. (AVTR) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism led by solid first-quarter 2024 results and operational workflow also looks promising. However, headwinds resulting from the loss of a significant number of customers and forex volatility are major downsides.Over the past year, this Zacks Rank #3 (Hold) stock has rallied 0.9% compared with the 4% rise of the industry and 27.1% growth of the S&P 500.The renowned provider of mission-cr ...

Avantor, Inc. (AVTR) recently released two innovative products aimed at revolutionizing the gene therapy harvest process. J.T.Baker Cell Lysis Solution and J.T.Baker Endonuclease are designed to enhance efficiency, reduce environmental impact, improve operational outcomes and preserve the integrity of viral particles. These products will also help to meet the rising demand for sustainable solutions in biopharmaceutical manufacturing.Significance of the AnnouncementPer Avantor, J.T. Baker Cell Lysis Solution ...

Innovative Solutions Optimize the Harvest Process in Gene Therapy Manufacturing Sustainably and at ScaleRADNOR, Pa., July 1, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced the launch of two innovative products that together sustainably optimize the gene therapy harvest process: J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease."These products ...

RADNOR, Pa., June 28, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2024 financial results before the market opens on Friday, July 26, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results. To hear a live audio webcast of the session, visit Events & Presentations in the Investo ...

RADNOR, Pa. , June 21, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Corey Walker has rejoined the company as President of Avantor's Laboratory Solutions business, reporting to CEO Michael Stubblefield.© 2017 - www.chorusphotography.com"Corey's deep knowledge of our end markets and industry, coupled with his familiarity with our organization and ...

Achieves 2025 Greenhouse Gas Emission reduction goals two years ahead of scheduleRADNOR, Pa., June 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, released its 2024 Sustainability Report today. The report highlights the meaningful progress Avantor made in 2023 against four Science for Goodness sustainability pillars: People & Culture, Innovation & Environment, Comm ...

RADNOR, Pa., May 29, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Fla. on Tuesday, June 11, 2024 at approximately 11:20 a.m. Eastern Time.  To hear a live audio webcast of the session, visit Events & ...

RADNOR, Pa., May 21, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at Bernstein's 40th Annual Strategic Decisions Conference in New York on Thursday, May 30, 2024 at approximately 8:00 a.m. Eastern Time.  To hear a live audio webcast of the session, visit Events & Present ...

RADNOR, Pa., May 3, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at approximately 10:00 a.m. Pacific Time.  To hear a live audio webcast of the session, visit Events & Presentations ...